TF and non-small cell lung carcinoma: The mechanisms by which individual peroxiredoxin (PRDX) controls LUSC in complementation of PRDX oxidation state, configuration, the client proteins [120], and transcription factor (TF) regulatory network for NSCLC should be explored [121].